Iovance Biotherapeutics, Inc. SEC filings IOVA
Iovance Biotherapeutics, Inc. has 1,003 filings in SEC EDGAR's recent list, going back to Oct 1, 2010. Its latest annual report, Form ARS, was filed on May 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Jun 18, 2026 | — |
| S-8 | Employee stock plan registration | Jun 18, 2026 | — |
| S-3ASR | Automatic shelf registration | Jun 18, 2026 | — |
| S-8 | Employee stock plan registration | Nov 12, 2025 | — |
| S-8 | Employee stock plan registration | Nov 12, 2025 | — |
| 424B5 | Prospectus supplement | Aug 22, 2025 | — |
| S-8 | Employee stock plan registration | Dec 13, 2024 | — |
| S-8 | Employee stock plan registration | Aug 9, 2024 | — |
| S-8 | Employee stock plan registration | Aug 9, 2024 | — |
| S-8 | Employee stock plan registration | May 10, 2024 | — |
| 424B5 | Prospectus supplement | Feb 21, 2024 | — |
| 424B5 | Prospectus supplement | Jul 11, 2023 | — |
| 424B5 | Prospectus supplement | Jul 10, 2023 | — |
| 424B5 | Prospectus supplement | Jun 16, 2023 | — |
| S-3ASR | Automatic shelf registration | Jun 16, 2023 | — |
| S-8 | Employee stock plan registration | Jun 12, 2023 | — |
| S-8 | Employee stock plan registration | Jun 12, 2023 | — |
| S-8 | Employee stock plan registration | May 10, 2023 | — |
| 424B5 | Prospectus supplement | Nov 18, 2022 | — |
| S-8 | Employee stock plan registration | Aug 4, 2022 | — |
| S-8 | Employee stock plan registration | Mar 11, 2022 | — |
| S-8 | Employee stock plan registration | Sep 23, 2021 | — |
| 424B5 | Prospectus supplement | Feb 9, 2021 | — |
| S-8 | Employee stock plan registration | Jun 19, 2020 | — |
| S-8 | Employee stock plan registration | Jun 19, 2020 | — |
| 424B5 | Prospectus supplement | May 29, 2020 | — |
| 424B5 | Prospectus supplement | May 27, 2020 | — |
| S-3ASR | Automatic shelf registration | May 27, 2020 | — |
| S-3/A | Filing | Sep 17, 2019 | — |
| S-3 | Shelf registration | Aug 30, 2019 | — |
| 424B5 | Prospectus supplement | Oct 12, 2018 | — |
| S-3MEF | Filing | Oct 11, 2018 | — |
| 424B5 | Prospectus supplement | Oct 11, 2018 | — |
| S-8 | Employee stock plan registration | Sep 7, 2018 | — |
| S-8 POS | Filing | Sep 7, 2018 | — |
| S-3 | Shelf registration | Sep 7, 2018 | — |
| 424B3 | Prospectus | Feb 13, 2018 | — |
| 424B5 | Prospectus supplement | Jan 25, 2018 | — |
| 424B5 | Prospectus supplement | Jan 24, 2018 | — |
| 424B3 | Prospectus | Jan 9, 2018 | — |
| S-3 | Shelf registration | Dec 28, 2017 | — |
| 424B3 | Prospectus | Dec 1, 2017 | — |
| 424B3 | Prospectus | Oct 26, 2017 | — |
| 424B5 | Prospectus supplement | Sep 21, 2017 | — |
| 424B5 | Prospectus supplement | Sep 19, 2017 | — |
| POS AM | Filing | Jul 31, 2017 | — |
| POS AM | Filing | Jul 31, 2017 | — |
| POS AM | Filing | Jul 31, 2017 | — |
| S-8 POS | Filing | Jul 31, 2017 | — |
| S-8 POS | Filing | Jul 31, 2017 | — |
| S-8 | Employee stock plan registration | May 3, 2017 | — |
| S-3 | Shelf registration | Dec 23, 2016 | — |
| S-8 | Employee stock plan registration | Nov 10, 2016 | — |
| 424B3 | Prospectus | Nov 3, 2016 | — |
| S-3 | Shelf registration | Oct 12, 2016 | — |
| POS AM | Filing | Oct 11, 2016 | — |
| POS AM | Filing | Oct 11, 2016 | — |
| 424B3 | Prospectus | Sep 2, 2016 | — |
| S-3/A | Amendment to form s-3 | Sep 1, 2016 | — |
| S-1/A | Amended registration statement | Aug 31, 2016 | — |
| S-1/A | Amended registration statement | Aug 1, 2016 | — |
| POS AM | Filing | Jul 29, 2016 | — |
| S-1 | Registration statement | Jul 1, 2016 | — |
| S-3 | Shelf registration | May 10, 2016 | — |
| POS AM | Filing | Jul 24, 2015 | — |
| POS AM | Filing | Jul 6, 2015 | — |
| POS AM | Post-effective amendment | Jun 23, 2015 | — |
| S-8 | Employee stock plan registration | Jun 18, 2015 | — |
| 424B5 | Prospectus supplement | May 4, 2015 | — |
| 424B5 | Prospectus supplement | May 1, 2015 | — |
| S-3/A | Filing | Apr 22, 2015 | — |
| S-3 | Shelf registration | Apr 8, 2015 | — |
| 424B3 | Prospectus | Mar 12, 2015 | — |
| 424B5 | Prospectus supplement | Feb 27, 2015 | — |
| S-3MEF | Filing | Feb 26, 2015 | — |
| 424B5 | Prospectus supplement | Feb 25, 2015 | — |
| 424B5 | Prospectus supplement | Dec 17, 2014 | — |
| S-3 | Shelf registration | Nov 20, 2014 | — |
| 424B3 | Prospectus | Sep 30, 2014 | — |
| POS AM | Post effective amendment no. 1 | Sep 11, 2014 | — |
| POS AM | Post-effective amendment to s-3 | Apr 11, 2014 | — |
| 424B3 | Prospectus | Jan 30, 2014 | — |
| S-1/A | Amended registration statement | Jan 21, 2014 | — |
| S-1/A | Amended registration statement | Jan 7, 2014 | — |
| S-1 | Registration statement | Dec 4, 2013 | — |
| 424B5 | Prospectus supplement | Apr 9, 2012 | — |
| S-3/A | Amendment to form s-3 | Dec 5, 2011 | — |
| S-3/A | Filing | Oct 27, 2011 | — |
| S-3/A | Form s-3/a | Sep 13, 2011 | — |
| S-3 | Shelf registration | Jun 28, 2011 | — |
Showing 90 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- IOVA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Carlos, CA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1425205
- Former names
- Lion Biotechnologies, Inc. (until Jun 5, 2017); Genesis Biopharma, Inc (until Sep 23, 2013); FREIGHT MANAGEMENT CORP (until Mar 8, 2010)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.